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Summary.-The cumulative radiation effect (CRE) is one of several empirical scalar
descriptions of biological effect which enable corrections to be made for gaps in
radiotherapy treatment. Predictions of this theory were tested using mouse crypt
regeneration and mouse skin as biological models. These experimental results are
discussed in terms of the dependence of tissue regeneration potential during a gap on
the biological effect achieved before the gap, and on gap length. A hypothesis is pro-
posed to reconcile the apparent conflict between the two experiments. While the
simple exponential gap formulation of the CRE is seen to be inadequate, insufficient
data are available at present to modify it.
THE CLINICAL RADIOTHERAPIST fre-
quently has to make allowance for a
gap occurring in the course of treatment.
This gap may occur by accident or design,
but some scale ofbiological effect ofradia-
tion damage in normal tissue is necessary
before a quantitative assessment of the
effect ofthe gap can be made.
At present available methods of assess-
ing radiation damage include several
empirical mathematical descriptions such
as NSD (Ellis, 1968), TDF (Orton & Ellis,
1973) and CRE (Kirk et al., 1971); and a
semi-empirical computer model (Cohen,
1971). The CRE system is based on a
monotonically increasing scalar assess-
ment of biological effect, implying that a
single number, the CRE, is taken to be a
complete and unambiguous description of
the level of biological effect generated by
the radiation, regardless of the way
in which the damage was inflicted. Such a
scalar description is an oversimplification
ofcomplex biological processes, but clinical
evidence currently available precludes the
formulation of more realistic models.
The gap formula used in conjunction
with the CRE system has been described
in detail elsewhere (Kirk et al., 1975). This
uses the simplest feasible formulation for
the loss of CRE during a gap, exponential
decay, and is compatible with the very
limited amount of clinical data, which
concerns gaps occurring in "mid-treat-
ment".
The aim ofthese experiments was to test
certain predictions of the CRE theory
concerning gaps in treatment schedules.
Since this theory relates to human con-
nective tissue, the numerical values of its
parameters can only be determined by
experiments on man which could not be
justified ethically. Recourse has therefore
to be made to animal systems to investi-
gate the qualitative aspects of the theory.
No animal model truly reflects the beha-
viour of human tissue, so that any choice
must be a compromise; the mouse intes-
tinal-crypt system was chosen as it yields
objective results. This advantage partially
compensates for the obviously different
numerical values of the parameters, but
the aspects of the theory investigated are
independent ofthese actual values. Animal
experiments such as these can never be
definitive, but should be regarded as aA. M. PERRY, R. HAMLET AND J. KIRK
guide to the design of clinical trials which
will form the only true test of the CRE
theory.
MATERIALS AND METHODS
Adult C3H/He mg mice (supplied by Bantin
and Kingman Ltd, ofHull), 10-15 weeks old,
wereirradiated withfractionated partial-body
doses of 250kV X-rays. The X-ray source
was a Siemens Stabilipan II mounted at the
bottom of a specially designed shielded
enclosure and producing a vertical beam of
HVT= 1 85 mm Cu. Final collimation was by
means of a 25mm slot in lead sheet of thick-
ness 3mm immediately beneath the mice to
restrict irradiation to the abdomen; the dose
rate to the intestines was 75 rad/min with
< 10% ofthis at the femur.
Using the intestinal-crypt microcolony
technique (Withers & Elkind, 1970), assay of
crypt regeneration was made 31 days after
the final irradiation dose. The histological
techniques used were as previously described
(Hamlet et at., 1976). In all the experiments
the time of irradiation within schedules was
kept constant to help avoid any artefacts due
to circadian rhythms. Postmortem examina-
tion was made of animals dying before the
day of assay.
RESULTS
The experiments were designed to
determine the fractional decay in the
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CRE, y, over a fixed time gap, as a func-
tion of the CRE already achieved, Ro.
For a constant number of fractions, y
depends on the position of the gap within
the schedule (Kirk et al., 1975). This decay
is measured in terms of the additional
dose required in the fractions remaining
after the gap to achieve a constant level of
biological damage, characterized by a
particular number of crypts per circum-
ference.
First, a simple reference schedule was
established into which gaps could be
introduced: of210radperfractiongiven in
18 fractions over 6 days; fractions were
given at 3 h intervals during the working
day; there was then an 18 h interval before
the nextgroup of3 fractions. This schedule
achieved an end-point of 32 crypts per
circumference (Fig. 1), which was the
lowest number of crypt per circumference
that could be achieved without loss of
life.
Retaining the same number offractions,
a gap of 2 days was introduced after each
third fraction, i.e. each day, in successive
experiments. Owing to possible tissue
repair during the gap, it was necessary to
give an additional dose per fraction in the
remaining fractions to reach the same end-
Total doso In rod
FIG. 1.-Crypt survival curve for the standard schedule of 210rad fractions at 3 1ractions/day.
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FIG. 2.-Results of assay doses for the diffe-
rent 18-fraction schedules with a 2-day gap.
Lines are least-mean-square fits to points.
Table gives the dose per post-gap fraction
to produce an end-point 32 crypts/circum-
ference for each schedule.
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4 C
5 0
Fractionation
schedule
3+ 15 fractions
6+ 12 fractions
9+ 9 fractions
12+ 6 fractions
15+ 3 fractions
Doses (rad) to
give 32 crypts
271-4+ 10
281-3 + 9
299-5 + 5
312-7 + 3
278-7+4
for controls, 30 unirradiated animals were
sampled over the period of experimenta-
tion, yielding a mean of 123-3 + 3-8 (s.e.)
crypts per circumference.
The allowance to be made for a gap in
treatment can be expressed in various
ways. It is particularly meaningful in the
clinical context to assess the effects of a
gap in terms of the additional dose which
must be given to compensate for it (Kirk
et al., 1975). That additional dose is
assumed to be distributed equally over the
fractions still to be given after gaps of
various lengths, and after various numbers
offractions inanotherwiseregularschedule
in which the total numbers of fractions
and the interfraction spacing, apart from
the gap, remain constant.
Fig. 3 shows the general features of the
additional dose curve predicted by the
experimental formulation of the decay in
CRE during a gap (from Kirk et al., 1975).
o The skewedness of the, cu1rveT should heb
particularly noted, with the greatest
additional dose required towards the end
of treatment. That curve was generated
using the CRE parameters derived from
human skin, but it can be readily demon-
strated that the general features of Fig. 3,
particularly the skewedness, are qualita-
tively the same for a wide range in values
of the exponents of the CRE formulation
for fractionated radiation schedules (Kirk
et al., 1971). Therefore the small change in
point of 32 crypts per circumference, a
near-tolerance end-point chosen so that
the effect of a gap in treatment could be
investigated over as wide a range oftissue
damageaspossible. Notlessthan 3different
additional trial doses per fraction for each
experiment were given. This enabled the
additional dose which would achieve the
necessary end-point to be determined by
extrapolating lines fitted to these experi-
mental points using an error-weighted
least-mean-square fit (Fig. 2). All the
results are listed in Table I. A minimum of
8 mice were used for each assay point and
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FIG. 3.-Theoretical total dose required to
achieve end-point, as a function ofgap posi-
tion for mouse gut.
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FIG. 4.-Additional total dose required to
achieve end-point V8 gap position for
mouse gut.
exponents used to take account of week-
ends in the original theory have little
effect in this instance.
The total additional dose required to
compensate for the 2-day gaps in the
schedules used in the irradiation of mouse
intestine are plotted in Fig. 4 against the
number of fractions before the gap. The
differences in shape of the two curves are
discussed below.
DISCUSSION
Comparison ofFigs. 3 and 4 shows that,
in contrast to the simple exponential
theory, much greater additional doses are
required to compensate for gaps occurring
earlier inthe course oftreatment and much
less additional dose later in treatment.
Regeneration in the mouse gut essentially
achieves a maximum repopulation rate
very soon after irradiation. This charac-
teristic of gut tissue could explain the
comparatively high additional dose re-
quired early in treatment, although it is
also possible that other factors such as cell
synchronization due to the shortfractiona-
tion interval might also play a part. On
the other hand, the comparatively small
additional dose required later suggests
that the irradiated tissue at that stage is
incompetent to effect repair.
Further information can be obtained
by using another animal tissue model such
as mouse skin. The data of Denekamp
(1973) can be interpreted in a different
wayto complementthe data obtainedwith
mouse gut. In Denekamp's experiments
mouse feet were irradiated according to
three basic protocols in which either 4, 9,
or 14 fractions of 300 rad were given at
5 fractions per week as an initial schedule.
Additional large single doses were then
given under the following conditions to
achieve a chosen end-point: (i) coincident
with the last dose of the above schedules,
(ii) on the following day, or (iii) after gaps
in treatment of 3, 7 or 14 days. The bio-
logical effects ofthe 3 initial protocols were
well below tolerance.
These experiments are similar in nature
to the experimental format for the mouse-
gut experiments, the essential difference
being the use of a single additional dose
rather than a regular schedule after the
gap. It is feasible to modify the results
ofthese protocols in which gaps occur into
the same structural form as the introduc-
tion of a gap in a simple regular schedule.
The effective additional total doses on an
equivalent regular-schedule protocol to
compensate for gaps of 3, 7 and 14 days in
treatment are plotted in Fig. 5 against the
number of fractions occurring before the
gap. Full details of this analysis can be
found in the Appendix.
The dependence ofthe fractional decay,
y, on the gap length, G, for a specified
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FiG. 5.-Additional total dose to achieve end-
point V8 gap position (N) for mouse skin.
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FIG. 6. y versus gap length in days, G, for
mouse skin.
FIG. 7. Fractional
function of CRE
mouse skin.
Ro
decay of CRE, y, as a
before the gap, Ro, for
CRE level, Ro, before the gap is shown in
Fig. 6. The family of lines for different
values of Ro (or N) demonstrates a frac-
tional linear decay for small gaps, with the
suggestion that these lines level off for
longer gap lengths. However, the most
dominant feature is the fact that y, which
is inversely related to the rate of regenera-
tion, becomes smaller as CRE increases.
This trend would lead to the impossible
conclusion that tissue regeneration be-
comes increasingly competentwithincreas-
ing radiation damage. It must be assumed
that some turning point is reached at
levels of damage well below tolerance.
This is clarified by Fig. 7, in which y is
plotted against Ro, the CRE achieved
before the gap. The family of curves for
different gap lengths demonstrates both
that the fractional decay is less for greater
gap lengths and, more importantly, that
forincreasing CRE levels yfallsincreasingly
rapidly until a minimum appears to be
reached. As the errors are undoubtedly
large, only trends in response should be
inferred from Figs. 6 and 7.
Compared with the single exponential
formulation of CRE (Kirk et al., 1975) the
mouse-gut experiments show a greater
regeneration potential early in the treat-
ment, and a much smaller regeneration
later although, as already pointed out,
that could be partially explained by a
maximal repopulation rate after small
doses of radiation. Therefore it would be
advisable to confine attention to the
results later in the schedule. On the other
hand, the mouse skin experiments show a
markedly increasing regeneration poten-
tial, apparently reaching a maximum
during treatment. The mouse skin results
are only available for the early part of the
schedule.
CONCLUSIONS
As a hypothesis, all the results discussed
above, from both the gut and skin experi-
ments, could be reconciled in the manner
sketched in Fig. 8, where the regeneration
potential is plotted against the level of
biological effect achieved before the gap.
That figure shows the regeneration poten-
tial rising to a maximum, before falling
asymptotically to zero as the radiation
I
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FiG. 8.-Hypothetical representation of
variation in regeneration potential with
increasing total dose.
damage approaches tolerance. Several
biological mechanisms are involved in
such a response. For small levels of accu-
mulated radiation dose early in treatment
it should be possible to consider tissue in
the light of a homoeostatically controlled
cell population. Under insult, such a
population responds actively to its control
by increasing its rate of repopulation and
thus its regeneration potential. In the
early phases oftreatment, this mechanism
could be responsible for the increased
regeneration potential shown in Fig. 8. For
increasing radiation damage the tissue
would be expected to become increasingly
incapable ofrepair. It is proposed that the
competition between these two mechan-
isms leads to the turning point in the
regeneration potential.
A further aspect ofthe loss ofbiological
effectislong-termresidualdamage. Recent
publications (Brown & Probert, 1975;
Hendry et al., 1977; Hunter & Stewart,
1977) indicate that some time after a
near-tolerance treatment schedule almost
as much radiation can again be given,
although some memory ofpreviousdamage
clearly exists. The amount ofre-irradiation
which can be given appears to depend on
the target tissue. Therefore, although the
initial decay in effect after treatment may
be fairly rapid, as some of the above work
suggests, residual damage cannot be
neglected as an important aspect of tissue
regeneration after treatment.
These results show that CRE and NSD
do not adequately allow for intervals in
treatment. If sufficient data were avail-
able, the simple exponential gap formula-
tion could be modified as a first step to-
wards a more realistic form. Any such
model must consider the following proper-
ties of tissue:
(i) increased regeneration potential
early in treatment,
(ii) progressive loss of regenerative po-
tential with increasing level of
biological effect, and
(iii) longer-term residual damage.
This paper does not offer a complete
solution to the pressing clinical problems
concerning gaps in treatment, but tries
to show the limitations of current theories
and to highlight the concepts necessary for
a more adequate model.
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APPENDIX.-A CRE TIME-GAP ANALYSIS
OF SOME OF DENEKAMP S MOUSE SKIN
DATA
INTRODUCTION AND PRESENTATION OF DATA
For convenience of presentation and analysis,
the descriptions ofthe radiation regimes used by
Denekamp (1973) are restated in a modified
form corresponding to the terminology of the
CRE system introduced by Kirk et al. (1977). In
that terminology, a fractionated schedule can
be briefly described by the notation:
[(d) N/T],
where d is the dose per fraction (in rad), N is
the number of fractions given, and T is the total
treatment time (in days).
In a treatment regime, with no gap, a hyphen
is placed between successive schedules; whereas
if a gap occurs, the length of the gap in days,
G, is written between hyphens and placed
between schedules as indicated below:
[(di) N1/T1]-G-[(d2) N2/T2]
The experimental regimes of Denekamp (1973)
can then be written as:
(a) (i) [(300) 3/3]-[(d+300) 1/1]
(ii) [(300) 4/4]-G-[(d) 1/1], where G=0, 7
or 14 days;
(b) (i) [(300) 8/10]-[(d +300) 1/1]
(ii) [(300) 9/11]-G-[(d) 1/1], where G=0, 3,
7 or 14 days;
(c) (i) [(300) 13/17]-[(d+300) 1/1]
(ii) [(300) 14/18]-G-[(d) 1/1], where G=0,
7 or 14 days,
where d is the single additional dose given after
the following nominal schedules: (a) 4 x 300 rad,
(b) 9x300 rad and (c) 14x 300 rad. The gaps
in treatment have been redefined according to
Kirk et al. (1975), as the number of intervening
days without treatment, so that:
G= "Denekamp gap" -1.
The single additional doses, d. given in these
regimes are recorded in Table I, and have been
estimated as means from the graphs of Fig. 5
in Denekamp, 1973. No reliable estimate can be
made of the errors on these doses, although they
must be considerable. The experimental regimes
quoted above all achieve the same end-point
(skin reaction of 1.5).
Justiftcation for applying the CRE system
As a general principle, the validity of the
CRE system can be most easily tested by
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presuming its applicability to some situation and
justifying that assumption a posteriori. The
situation in this case is afforded by the above
regimes without gaps. For each of the 3 groups
of regimes, there are 2 ((i) and (ii)) with G= 0.
The additional single doses, d, given on these
regimes are given in the first and second lines
TABLE I.-Single additional doses (d) to
compensate for the gaps used in Dene-
kamp's experiments
Gap Schedules
("Dene- , A
I
kamp") (a) 4 x 300 (b) 9 x 300 (c) 14 x 300
0 1525 1300 900
I 2045 1600 1110
4 - 1750
8 1975 2000 2025
15 2080 2160 2150
in Table I, respectively. These experimental
regimes can then be written explicitly as follows:
(a) (i) [(300) 3/3]-[(1825) 1/1]; R = 2040
(ii) [(300) 4/4]-[(2045) 1/1]; R = 2315
Mean R= 2175
(b) (i) [(300) 8/10]-[(1600) 1/1]; R = 2160
(ii) [(300) 9/11]-[(1600) 1/1]; R = 2225
Mean R = 2195
(c) (i) [(300) 13/17]-[(1200) 1/1]; R = 2160
(ii) [(300) 14/18]-[(1110) 1/l];R=2165
Mean R = 2165
The CREs, R1 and R2, achieved by the first and
second schedules, respectively, of these regimes
taken alone can be evaluated using the formula-
tion for fractionated treatment schedules pre-
sented in Kirk et al. (1971):
RF = D . N-0-24. T-0-119 (1)
and compounded to find the CRE, R, achieved
by the regime using the equation introduced by
Kirk et al. (1977):
Rs=Ris +R2s, (2)
where 1/s= 0-65. The CREs thus found are
shown above alongside the corresponding
regimes, and prove to be reasonably close
numerically. Certainly, no particular trend is
evident. For these groups ofregimes, the greatest
variation in CRE is found in Group (a). How-
ever, the closeness of the mean CREs for each
group suggests that the CRE system can be
applied to this situation without incurring great
error, and that mouse skin has a similar kinetic
response to that of human skin. It could there-
fore be argued that the CRE values found above
could be averaged, for practical purposes, to
find the mean CRE for the end-point used,
which is 2175. It is useful for later analysis to
note that this same biological end-point would
have been achieved with the simple schedule of:
[6600 (22/30)]=-[(300) 22/30],A. M. PERRY, R. HAMLET AND J. KIRK
approximated to the nearest whole number of
fractions; where it has been assumed that doses
per fraction of 300 rad were given at 5 fractions
per week, following the pattern of the original
schedules.
Having justified the application of the CRE
system to experimental results of the mouse
skin model for simple situations involving no gap
in treatment, attention can now be given to
regimes in which single additional doses were
given after varying intervals.
Analysis of time-gap data
In the following analysis, the effect of a gap
in treatment will be considered in terms of both
the fractional decay in CRE during the gap and
the additional dose required to be given under
specific conditions to compensate for the gap.
The fractional decay, y, in CRE during a gap
is defined as the ratio of the CRE remaining
after the gap to the CRE achieved before the
gap. The fractional decay can be evaluated
from the following expression (described in Kirk
et al. (1977)):
Rs=Ris.ys +R2s, (3)
Rs R2s
yS= Ris 9 so that
where the terminology is that defined above.
The basic data for assessing the effect of a gap in
treatment are furnished by the groups ofregimes
(a) (ii), (b) (ii) and (c) (ii), quoted above, for
positive gaps, and the corresponding single
additional doses from Table I. The CREs, R1,
achieved before the gap after N1 fractions have
been given can be calculated using Equation
(1), and are listed for each of the groups of
regimes in Table II. The CRE, R2, achieved by
the schedule after the gap, is numerically equal
to the single additional dose, d, since the
schedule consists of one fraction. The CRE, R,
corresponds to the end-point denoted by the
reaction level of 1-5, and is taken to be 2160;
TABLE II.-The fractional decay, (y), of
the CRE during gaps in the various
regimes, calculated from equation (4) and
the CRE exponential gap formula. The
CREs (R1) achieved after N1 fractions
on Denekamp's regimes are calculated
from Equation (1)
Regime
r--
(a)(ii) (b)(ii) (c)(ii)
Nl:Ri NL:Ri NL:Ri
G 4:740 9:1225 14:1620
3 - 0-768
7 0 777 0-428 0-290
14 0-458 0-023 0-059
y calculated
from
exponential
gap
formula
0-976
0-946
0-894
for convenience of later calculation, the CRE
achieved by the simple schedule of 6600 rad
given in 22 fractions in 30 days noted earlier is
chosen in preference to the mean of the regimes
without gaps, although the difference is trivial
and well within experimental error. The frac-
tional decay, y, can then be readily evaluated
Lising equation (4) for various gap lengths and
positions in the course of treatment (defined in
terms of the number of fractions given, N1, and
the CRE, R1, achieved before the gap as N1: R1)
and are recorded in Table II. These results may
be more easily appreciated from Figs. 6 and 7
in the main text; in Fig. 6, the dependence ofthe
fractional decay, y, on the gap length, G, for a
specified CRE R1, before the gap is shown,
whereas in Fig. 7, y is plotted against R1, the
CRE achieved before the gap for specific gap
lengths. Denekamp (1973) has interpreted the
above data in terms of short-term repair and
repopulation, observing that in the 14-fraction
experiment repopulation was becoming sig-
nificant. When there was a gap in treatment, it
was noted that the rate of repopulation de-
creased with time, under the influence of homo-
eostatic control as the population approached
the original size. This biological interpretation
is in agreement with the hypothesis proposed in
the conclusions ofthe main paper.
For the purposes ofcomparison, the fractional
decays in CRE predicted by the exponential
formulation derived by Kirk et al. (1975) for the
same gap lengths are also presented in Table II.
The fractional decays from the Denekamp data
are not in good agreement with the exponential
formulation for the positions at which gaps were
introduced. However, it ispostulated in the main
text, from a consideration of the available
evidence, that the fractional decays will vary
considerably depending on the biological effect
achieved in the course ofa schedule before a gap,
reflecting the changing repopulation potentials.
The repopulation term, T-0'11, in Equation (1)
describes empirically an integration of the vary-
ing repopulation potentials which occur during
treatment. The exponential formulation is an
inadequate description of the effects of gaps in
treatment, having an "average" and fixed
decay constant matching the repopulation term.
However, the inadequacies of that formulation
and the implication of the above results are
more fully explored in the main text.
A particularly meaningful alternative way of
assessing the effects of a gap in treatment in the
clinical context is in terms ofthe additional dose
which must be given to compensate for a gap
occurring in a simple regular schedule. In the
analysis to follow, it is assumed that the addi-
tional dose is distributed equally over the frac-
tions still to begiven after gaps ofvariouslengths
are introduced, following various numbers of
fractions in a schedule when the total number
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of fractions and the inter-fraction spacing, apart
from the gap, remain constant. This form of
analysis allows ready comparison with the
"additional dose" predictions ofthe CRE system
(Kirk et at., 1975) and with data presented
in this paper. It is necessary to convert the
Denekamp data from the single additional dose
assessment to that of a distributed additional
dose given in a regular schedule for comparison,
rather than the reverse, as it can be demon-
strated, as shown above, that it is justifiable to
apply the CRE system to the data of Denekamp
(1973) for the purposes of manipulation, but
not to the mouse-gut data presented in this
paper. In Table I, the single additional doses
which require to be given after different numbers
of fractions and gaps to achieve a particular
end-point are set out for the groups of regimes
(1) (ii), (b) (ii) and (c) (ii). It was shown earlier
that that same end-point described by a CRE
of 2160 can also be achieved by the simple
regular schedule:
[6600 (22/30)] = [(300) 22/30],
which follows the pattern of the above regimes
before the gaps. If N1 fractions, as recorded in
Table II, are given before the gap which could
be considered as being introduced into the above
simple schedule, and if the total number of
fractions, 22, remains unchanged, the number of
fractions, N2, to be given after the gap is:
N2=22-N1
Therefore, for the same interfraction spacing of
dailyfractionation, the effective secondschedules
following the gap for Regimes (a) (ii), (b) (ii)
and (c) (ii) must take the respective forms:
(a) (ii) [D2 (18/26)]
(b) (ii) [D2 (13/19)]
(c) (ii) [D2 (8/12)]
where D2 is the total dose given in these
schedules. In the terminology of Equation (3),
each of these schedules achieves the CRE, R2,
which is numerically equivalent to the single
additional doses, d, listed in Table I. Using
Equation (1), the dose, D2, to be given on each
of the regimes (a) (ii), (b) (ii) and (c) (ii) for
non-zero gaps can be simply calculated and are
recorded in Table III. The effective additional
TABLE III.-Total doses (D2) required
300rad/fraction schedules after gaps
compensate for decay of CRE
Regime
A
G (a)(ii)
3
7
14
5655
5955
(b)(ii)
4480
5115
5525
in
to
(c)(ii)
4385
4655
doses, A, required to compensate for gaps after
the nominal schedules; (a) 4 x 300 rad, (b)
9 x 300 rad and (c) 14 x 300 rad; can be found
respectively from:
(a) A= 1200+D2-6600
(b) A= 2700+D2-6600
(c) A= 4200+D2-6600,
and are summarized in Table IV. These results
can be more clearly visualized from Fig. 5 in
TABLE IV.-Effective additional doses (A)
required to compensatefor decay of ORE.
(See text)
Regime
G (a)(ii) (b)(ii) (c)(ii)
3 580 -
7 255 1215 1985
14 555 1625 2255
the main text ofthis paper, where their implica-
tions are compared with other relevant data and
where the relevance ofthese studies on the effect
of intervals in treatment to clinical practice and
future efforts is fully explored and reviewed.
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